Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > All news > ACT EU: creating a better environment for clinical trials through collaboration

https://www.ema.europa.eu/en/news/act-eu-creating-better-environment-clinical-trials-through-collaboration

Ryan McArthur 23 June 2023 All news
  • ← Pharmya 10th Anniversary Celebration!
  • Report on pharmacovigliance tasks from EU Member states and the EMA 2019-2022 →

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2024
  • Questions and Answers on the Windsor Framework and medicines for human use (updated 25 October 2024)
  • Annual report of the Pharmacovigilance Inspectors’ Working Group for 2023
Copyright © 2018 - Pharmya - Legal terms - Quality Policy